FDA approves 2006 strain of flu vaccine

Aug 03, 2006

The U.S. Food and Drug Administration has approved the manufacture of this year's seasonal influenza vaccine.

The vaccine is designed to fight new virus strains scientists believe are likely to cause flu in the Northern Hemisphere during 2006-07.

Each year influenza vaccine manufacturers submit information and samples to the FDA of the virus strains to be produced for the upcoming seasonal influenza season. This season's FDA-approved formulation is identical to that recommended by the World Health Organization. The formulation includes one strain that was used in last year's vaccine and two new strains.

Seasonal flu vaccines do not protect against avian influenza, which is caused by different viral strains.

The U.S. Centers for Disease Control and Prevention say up to 20 percent of the U.S. population is stricken by influenza annually, with about 200,000 people requiring hospitalization and approximately 36,000 people dying from the disease.

At high risk for serious flu complications are elderly people, children and people with certain chronic medical conditions.

Copyright 2006 by United Press International

Explore further: Researchers tackle 'virtually ignored' psychological study of spite

add to favorites email to friend print save as pdf

Related Stories

Protecting competition horses from the flu

Nov 05, 2013

A deep hacking cough, a runny nose and fever—just like humans, horses can suffer badly when struck down by the flu. Although equine influenza is rarely fatal, it is highly contagious and can seriously disrupt ...

Researchers use microRNA to trap mutant viruses in the lab

Aug 12, 2013

(Phys.org) —It's a scenario straight out of a sci-fi horror flick. Scientists take a deadly virus that people can only catch from birds and genetically engineer it so we can give it to each other. Unfortunately, ...

Recommended for you

Cancer patients need anxiety, depression screening

8 hours ago

(HealthDay)—It is important to recognize and treat anxiety or depression among cancer patients, according to a clinical guideline published online April 14 in the Journal of Clinical Oncology.

User comments : 0

More news stories

Volitional control from optical signals

(Medical Xpress)—In their quest to build better BMIs, or brain-machine-interfaces, researchers have recently begun to look closer at the sub-threshold activity of neurons. The reason for this trend is that ...

Neuroimaging: Live from inside the cell

A novel imaging technique provides insights into the role of redox signaling and reactive oxygen species in living neurons, in real time. Scientists of the Technische Universität München and the Ludwig-Maximilians-Universität ...

Mantis shrimp stronger than airplanes

(Phys.org) —Inspired by the fist-like club of a mantis shrimp, a team of researchers led by University of California, Riverside, in collaboration with University of Southern California and Purdue University, ...